noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking. 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing 
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model 
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges 
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness 
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions 
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing 
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip 
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development 
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure 
AUSTIN, Texas, Jan. 19, 2016 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. today announced it conducted a new audio interview with PositiveID Corporation (“PositiveID” or the “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics. In the interview, which can be heard at http://smallcapvoice.com/blog/1-18-16-smallcapvoice-interview-with-positiveid-corporation-psid, William J. Caragol, Chairman and CEO of PositiveID, discusses the Company’s 2015 accomplishments and 2016 goals, including an overview of its two recent acquisitions.
In December 2015, PositiveID acquired two complementary businesses, E-N-G Mobile Systems, Inc. (“ENG”) and Thermomedics, Inc., which bring new revenue streams with significant growth prospects to PositiveID, while the Company works to complete the development and testing of its Firefly Dx real-time pathogen detection system. The acquisitions bring synergistic product offerings, experienced management, and a strong customer and distribution network.
ENG is a leader in mobile labs, homeland security and communications vehicles, which has recorded average unaudited revenues annually of more than $4 million. Thermomedics markets the Caregiver® non-contact thermometer, which is a clinical grade, FDA-cleared, infrared thermometer for measurement of forehead temperature in adults, children, and infants, without contact, in under two seconds.
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.
About PositiveID Corporation
PositiveID Corporation is a life sciences company focused on detection and diagnostics, with an extensive patent portfolio. PositiveID specializes in the development of microfluidic systems for the automated preparation of and performance of biological assays. PositiveID is also a leader in the mobile technology vehicle market, with a focus on the laboratory market and homeland security. For more information on PositiveID, please visit http://www.psidcorp.com, or connect with PositiveID on Twitter, Facebook or LinkedIn.
[update] Statements about PositiveID's future expectations in this press release and those made in its interview with SmallCapVoice.com, including the likelihood that PositiveID expects to close the acquisition during the fourth quarter of 2015; the likelihood that Firefly can lead to treatment scenarios at the point of need that are not possible with existing systems; constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID’s actual results could differ materially from expected results. These risks and uncertainties include, without limitation, PositiveID’s ability to target the bio-threat detection and rapid medical testing sectors; PositiveID’s ability to complete the development and commercialization of its Firefly Dx system; as well as other risks. Additional information about these and other factors that could affect PositiveID’s business is set forth in its various filings with the Securities and Exchange Commission, including those set forth in PositiveID’s 10-K filed on March 30, 2015, and 10-Qs filed on August 13, 2015, May 15, 2015, and November 17, 2014, under the caption “Risk Factors.” PositiveID undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
Contact for PositiveID Corporation Allison Tomek 561-805-8044 [email protected] Contact for SmallCapVoice.com: Stuart T. Smith 512-267-2430 [email protected]
